Century Therapeutics (IPSC) Research & Development (2022 - 2025)
Historic Research & Development for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to $22.5 million.
- Century Therapeutics' Research & Development fell 1726.9% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $105.3 million, marking a year-over-year increase of 516.65%. This contributed to the annual value of $107.2 million for FY2024, which is 1567.68% up from last year.
- Latest data reveals that Century Therapeutics reported Research & Development of $22.5 million as of Q3 2025, which was down 1726.9% from $26.9 million recorded in Q2 2025.
- Century Therapeutics' 5-year Research & Development high stood at $29.4 million for Q4 2024, and its period low was $21.2 million during Q1 2022.
- Its 4-year average for Research & Development is $24.9 million, with a median of $24.9 million in 2023.
- Its Research & Development has fluctuated over the past 5 years, first soared by 3175.01% in 2024, then plummeted by 1726.9% in 2025.
- Quarter analysis of 4 years shows Century Therapeutics' Research & Development stood at $25.6 million in 2022, then fell by 12.86% to $22.3 million in 2023, then soared by 31.75% to $29.4 million in 2024, then dropped by 23.32% to $22.5 million in 2025.
- Its last three reported values are $22.5 million in Q3 2025, $26.9 million for Q2 2025, and $26.6 million during Q1 2025.